About Aveo Pharmaceutical
Aveo Pharmaceutical is a company based in Palghar (India) founded in 2015 was acquired by LG Chem in October 2022. The company has 48 employees as of July 31, 2025. Aveo Pharmaceutical offers products and services including Antidiabetic Tablets, Health Supplements, Cephalosporins, and Oral Suspensions. Aveo Pharmaceutical operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Palghar, India
- Employees 48 as on 31 Jul, 2025
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aveo Pharmaceuticals Pvt. Ltd.
- Date of Incorporation 17 Jan, 2015
- Jurisdiction Palghar, Maharashtra, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aveo Pharmaceutical
Aveo Pharmaceutical offers a comprehensive portfolio of products and services, including Antidiabetic Tablets, Health Supplements, Cephalosporins, and Oral Suspensions.
Tablets for managing diabetes and related health conditions.
Supplements with vitamins and herbs for general wellness support.
Oral antibiotics for treating bacterial infections effectively.
Liquid medications for easy administration to patients.
Funding Insights of Aveo Pharmaceutical
Detailed funding history for Aveo Pharmaceutical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Aveo Pharmaceutical
Aveo Pharmaceutical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LG Chem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer and supplier of automotive battery to OEMs
|
Locked | Locked | Locked |
Investor details for Aveo Pharmaceutical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aveo Pharmaceutical
Investment portfolio details for Aveo Pharmaceutical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aveo Pharmaceutical
Detailed financials for Aveo Pharmaceutical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aveo Pharmaceutical Comparisons
Peer comparison for Aveo Pharmaceutical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aveo Pharmaceutical
Aveo Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
Detailed competitors of Aveo Pharmaceutical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aveo Pharmaceutical
Complete news archive for Aveo Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aveo Pharmaceutical
Aveo Pharmaceutical was founded in 2015.
Aveo Pharmaceutical is headquartered in Palghar, India. It is registered at Palghar, Maharashtra, India.
As of Jul 31, 2025, the latest employee count at Aveo Pharmaceutical is 48.
Annual revenue of Aveo Pharmaceutical is $15.56M as on Mar 31, 2024.
Aveo Pharmaceutical was founded in 2015 and is based in Palghar, India. Activities are centered in the pharmaceutical sector, with drug manufacturing and marketing handled as core operations. Other related services are extended to support industry needs. The company is led by Managing Director Arvind Awadhnath Sharma, overseeing functions from its Indian location.
Aveo Pharmaceutical offers Antidiabetic Tablets, Health Supplements, Cephalosporins, and Oral Suspensions.
Aveo Pharmaceutical has 1 investor. Key investors include LG Chem.